IL15 and neoplasm: Additionally, a triple therapy combining NK cell immunotherapy, VSV-IL-15 virotherapy, and PD-1 blockade further strengthened immune cell activation and function, leading to more tumor regressions, with some patients achieving complete tumor eradication (158).